id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-E-0153-0008,FDA,FDA-2011-E-0153,Letter from U.S. Patent and Trademark Office to Merchant & Gould P. C.,Other,Letter(s),2014-04-02T04:00:00Z,2014,4,2014-04-02T04:00:00Z,,2014-04-02T12:40:31Z,,0,0,0900006481695cbf
FDA-2011-E-0153-0007,FDA,FDA-2011-E-0153,FDA\CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T14:09:25Z,,0,0,090000648119d582
FDA-2011-E-0153-0006,FDA,FDA-2011-E-0153,Regulatory Review Period for Purposes of Patent Extension: EGRIFTA,Notice,General Notice,2012-05-04T04:00:00Z,2012,5,2012-05-04T04:00:00Z,2012-07-04T03:59:59Z,2012-05-04T14:00:27Z,2012-10808,0,0,090000648100504b
FDA-2011-E-0153-0005,FDA,FDA-2011-E-0153,FDA\CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-04-18T04:00:00Z,2012,4,2012-04-18T04:00:00Z,,2012-04-18T14:19:10Z,,0,0,0900006480ff395a
FDA-2011-E-0153-0004,FDA,FDA-2011-E-0153,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,Letter(s),2011-09-16T04:00:00Z,2011,9,2011-09-16T04:00:00Z,,2011-09-16T14:59:23Z,,0,0,0900006480f1f2e8
FDA-2011-E-0153-0003,FDA,FDA-2011-E-0153,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2011-05-04T04:00:00Z,2011,5,2011-05-04T04:00:00Z,,2011-05-04T16:35:01Z,,0,0,0900006480c3f378
FDA-2011-E-0153-0001,FDA,FDA-2011-E-0153,"Teratechnologies, Inc. (Merchant & Gould P.C.) - Patent Extension Application",Other,APP-Application,2011-03-10T05:00:00Z,2011,3,2011-03-10T05:00:00Z,,2013-07-27T23:47:03Z,,0,0,0900006480c04c3b
FDA-2011-E-0153-0002,FDA,FDA-2011-E-0153,U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2011-03-10T05:00:00Z,2011,3,2011-03-10T05:00:00Z,,2013-07-27T23:47:03Z,,0,0,0900006480c04c3d